Situation:
Estimates show that developing a single prescription drug that gains market approval cost $2.6 billion. The further a drug goes into this process, from R&D to clinical trials to manufacturing, the more costly this financial roadblock becomes. Kentucky-based Bexion Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of innovative cures for cancer. Although it has been a challenge, the Bexion team will not give up on what is perhaps life-changing and sought-after cancer treatments.Solution:
Bexion received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health in 2009. The U.S. Small Business Administration, which helps Americans start, grow, expand and recover their businesses, administers the SBIR and its sister program, Small Business Technology Transfer (STTR). Through these competitive award programs, SBA ensures that the nation’s high-tech,... Read More